Tag: contraceptive devices market forecast

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The contraceptive devices market has been experiencing significant growth recently, driven by increasing awareness and advancements in reproductive health. As family planning gains more attention worldwide, the market continues to evolve with new technologies and expanding access, promising steady growth in the coming years. Let’s explore the current market size, key drivers, product segments, emerging trends, leading companies, and regional dynamics shaping this sector.

Steady Growth and Market Size Expectations in the Contraceptive Devices Market

The contraceptive devices market has seen a strong upward trajectory in recent years. It is projected to grow from $13.55 billion in 2025 to $14.4 billion in 2026, marking a compound annual growth rate (CAGR) of 6.3%. This expansion in the past can largely be linked to increased awareness about family planning, government-backed population control initiatives, the rise in unintended pregnancies, wider reproductive health services, and improved availability of over-the-counter contraceptives. Looking ahead, the market is expected to continue robust growth, reaching $18.31 billion by 2030 with a CAGR of 6.2%. Factors contributing to this forecast include a stronger emphasis on reproductive autonomy, rising demand for long-term and easy-to-use contraceptive options, growth in digital health and online pharmacy platforms, greater adoption of male contraceptive methods, and the influence of public and NGO-led sexual health programs. Notable trends during this period involve increased use of long-acting reversible contraceptives, female-controlled options, non-hormonal devices, and expanded access through online and public distribution channels, as well as a focus on dual protection against pregnancy and sexually transmitted infections (STIs).

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

The Rising Impact of Sexually Transmitted Diseases on Market Demand

One of the critical factors driving the contraceptive devices market is the increasing incidence of sexually transmitted diseases (STDs). These infections, primarily spread through sexual contact, affect multiple body systems and can lead to serious health issues. The rise in STDs is attributed to factors such as increased sexual activity, inadequate protection use, limited sexual health education, and barriers to healthcare and testing services. Contraceptive devices, especially condoms, play a crucial role in preventing the transmission of STDs by acting as a protective barrier against infectious fluids and lesions. For example, a July 2024 report by the UK Health Security Agency highlighted that England recorded 401,800 new STI diagnoses in 2023, a 4.7% increase from 2022. Gonorrhea cases rose by 7.5%, from 79,268 to 85,223, while syphilis diagnoses increased by 9.4%, from 8,693 to 9,513. These rising infection rates underscore the growing need for effective contraceptive devices in the market.

Breakdown of the Contraceptive Devices Market by Product Types and Technologies

This market is segmented across various dimensions to capture the diverse range of products and technologies available. By product type, the categories include Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms and Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, and other types. When considering technology, the market is divided into Hormonal Contraceptives and Barrier Contraceptives. Distribution channels encompass Hospital Pharmacies, Retail Pharmacies, Clinics, Online Platforms, Public Channels and NGOs, and other pathways. Further subsegment details include male condoms, vasectomy devices, injections, and pills within the male devices category; female condoms and various vaginal barrier methods under female devices; and various types of IUDs and implants broken down by their hormonal and non-hormonal nature.

Access The Complete Contraceptive Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Innovations in Contraceptive Devices Highlighted by Market Trends

Leading firms in the contraceptive devices space are continually innovating to meet consumer needs for convenience and efficacy. A prime example is the contraceptive vaginal ring, a flexible, hormone-releasing device designed for monthly insertion that prevents pregnancy by releasing hormones to inhibit ovulation and thicken cervical mucus. In October 2023, US-based pharmaceutical company Xiromed LLC introduced the EnilloRing, a vaginal ring combining etonogestrel and ethinyl estradiol. This device is intended for long-term use, staying in place for three weeks followed by a one-week break, offering an easy-to-use birth control solution that aligns with modern lifestyles.

Key Players Driving Competition and Development in the Contraceptive Devices Market

The competitive landscape of the contraceptive devices market features several major companies that shape industry trends and product availability. These include Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, and Pregna International Limited, among others. Their ongoing research and development efforts continue to introduce new contraceptive options and improve existing ones.

Regional Market Distribution and Growth Patterns in the Contraceptive Devices Sector

Geographically, North America held the largest share of the contraceptive devices market in 2025. Meanwhile, Asia-Pacific is forecasted to be the fastest-growing region throughout the projection period. The report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global overview of market expansion and regional opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Contraceptive Devices Market During The Forecast Period?

The contraceptive devices market has experienced robust expansion in recent years. It is projected to increase from $13.55 billion in 2025 to $14.4 billion in 2026, at a compound annual growth rate (CAGR) of 6.3%. This growth during the historic period can be ascribed to factors such as a rise in awareness of family planning methods, government-backed population control programs, a higher prevalence of unintended pregnancies, the expansion of reproductive health services, and the growing availability of over-the-counter contraceptive products.

The contraceptive devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $18.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. The expansion during this period stems from a heightened emphasis on reproductive autonomy and women’s health, a growing need for long-term and easy-to-maintain contraception, the proliferation of digital health services and online pharmacy platforms, increased acceptance of male contraceptive options, and more public and NGO-driven sexual health campaigns. Key developments expected during the forecast timeframe encompass a rise in the uptake of long-acting reversible contraceptives, an escalating demand for contraceptive methods controlled by women, greater acceptance of non-hormonal contraceptive devices, broadened access to contraception via online and public avenues, and an increased focus on offering dual protection against both pregnancy and STIs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Key Drivers Are Fueling The Growth Of The Contraceptive Devices Market?

The increasing prevalence of sexually transmitted diseases is projected to drive the growth of the contraceptive device market in the coming years. Sexually transmitted diseases (STDs) are infections primarily transmitted through sexual contact, affecting various parts of the body and potentially leading to a range of symptoms and significant health complications. The surge in sexually transmitted diseases is linked to increased sexual activity, a lack of adequate protection, insufficient sexual health education, and challenges in accessing healthcare and testing. Contraceptive devices, particularly condoms, are essential for addressing sexually transmitted diseases because they create a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, a report published by the UK Health Security Agency, a UK-based government agency, revealed that England had 401,800 new STI diagnoses in 2023, marking a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses of gonorrhea rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Meanwhile, infectious syphilis diagnoses saw a 9.4% increase, rising from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is propelling the expansion of the contraceptive device market.

What Are The Key Segment Divisions In The Contraceptive Devices Market Segment Structure?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

What Trends Are Influencing The Contraceptive Devices Market?

Major companies operating in the contraceptive device market are actively engaged in developing innovative products, such as contraceptive vaginal rings, to offer a convenient, low-maintenance method of birth control with a once-a-month insertion. A contraceptive vaginal ring is a pliable, hormone-releasing device inserted into the vagina that prevents pregnancy by consistently releasing hormones to inhibit ovulation and increase the thickness of cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, introduced the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is intended for long-term use, staying in place for three weeks, followed by a one-week ring-free interval to effectively prevent pregnancy.

Which Organizations Are Engaged In The Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Get The Full Contraceptive Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Region Holds The Highest Market Share In The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Contraceptive Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Contraceptive Devices Market At The End Of The 2026–2030 Forecast Period?

The contraceptive devices market has demonstrated robust expansion over recent years. It is projected to increase from $13.55 billion in 2025 to $14.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The market’s historical growth can be attributed to factors such as growing awareness of family planning methods, government-supported population control initiatives, an increasing occurrence of unintended pregnancies, the expansion of reproductive health services, and the rising availability of over-the-counter contraceptive products.

The contraceptive devices market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a value of $18.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This expected growth throughout the forecast period stems from factors such as a heightened focus on reproductive autonomy and women’s health, an increasing need for long-term and easily maintainable contraception, the expansion of digital health and online pharmacy platforms, the rising adoption of male contraceptive solutions, and an increase in public and NGO-led sexual health initiatives. Prominent trends for this period encompass the growing adoption of long-acting reversible contraceptives, a surge in demand for female-controlled contraceptive options, increasing acceptance of non-hormonal contraceptive devices, broadened access to contraception through online and public channels, and an intensified focus on dual protection against both pregnancy and STIs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Drivers Are Shaping The Future Growth Of The Contraceptive Devices Market?

The increasing occurrence of sexually transmitted diseases is anticipated to drive the expansion of the contraceptive device market in the foreseeable future. These infections, primarily spread via sexual contact, can impact various body parts and potentially result in diverse symptoms and health issues. The surge in sexually transmitted diseases can be attributed to heightened sexual activity, insufficient protection, inadequate sexual health education, and difficulties in accessing healthcare and testing. Contraceptive devices, particularly condoms, are crucial for combating sexually transmitted diseases as they offer a protective barrier, thereby lowering transmission risk by preventing direct contact with infected fluids and lesions. For instance, a report released in July 2024 by the UK Health Security Agency, a UK-based government body, revealed that in England, new STI diagnoses reached 401,800 in 2023, signifying a 4.7% rise from the 383,789 cases documented in 2022. Gonorrhea diagnoses specifically climbed by 7.5%, moving from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses experienced a 9.4% increase, moving from 8,693 in 2022 to 9,513 in 2023. Consequently, the rising prevalence of sexually transmitted diseases is a key factor propelling the growth of the contraceptive device market.

What Segment Types Make Up The Contraceptive Devices Market?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Which Market Trends Are Creating New Opportunities In The Contraceptive Devices Market?

Leading companies within the contraceptive device market are developing cutting-edge products, such as contraceptive vaginal rings, to provide a convenient and low-maintenance method of birth control with just one insertion per month. A contraceptive vaginal ring functions as a flexible, hormone-emitting device inserted into the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. The EnilloRing, created by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is engineered for extended application, staying in place for three weeks, after which it is followed by a one-week ring-free interval to effectively prevent pregnancy.

Who Are The Key Players Driving Competition In The Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Read the full contraceptive devices market report here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Geographic Regions Are Influencing Demand In The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Contraceptive Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Contraceptive Devices Market At The End Of The 2026–2030 Forecast Period?

The contraceptive devices market has demonstrated robust expansion over recent years. It is projected to increase from $13.55 billion in 2025 to $14.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The market’s historical growth can be attributed to factors such as growing awareness of family planning methods, government-supported population control initiatives, an increasing occurrence of unintended pregnancies, the expansion of reproductive health services, and the rising availability of over-the-counter contraceptive products.

The contraceptive devices market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a value of $18.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This expected growth throughout the forecast period stems from factors such as a heightened focus on reproductive autonomy and women’s health, an increasing need for long-term and easily maintainable contraception, the expansion of digital health and online pharmacy platforms, the rising adoption of male contraceptive solutions, and an increase in public and NGO-led sexual health initiatives. Prominent trends for this period encompass the growing adoption of long-acting reversible contraceptives, a surge in demand for female-controlled contraceptive options, increasing acceptance of non-hormonal contraceptive devices, broadened access to contraception through online and public channels, and an intensified focus on dual protection against both pregnancy and STIs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Drivers Are Shaping The Future Growth Of The Contraceptive Devices Market?

The increasing occurrence of sexually transmitted diseases is anticipated to drive the expansion of the contraceptive device market in the foreseeable future. These infections, primarily spread via sexual contact, can impact various body parts and potentially result in diverse symptoms and health issues. The surge in sexually transmitted diseases can be attributed to heightened sexual activity, insufficient protection, inadequate sexual health education, and difficulties in accessing healthcare and testing. Contraceptive devices, particularly condoms, are crucial for combating sexually transmitted diseases as they offer a protective barrier, thereby lowering transmission risk by preventing direct contact with infected fluids and lesions. For instance, a report released in July 2024 by the UK Health Security Agency, a UK-based government body, revealed that in England, new STI diagnoses reached 401,800 in 2023, signifying a 4.7% rise from the 383,789 cases documented in 2022. Gonorrhea diagnoses specifically climbed by 7.5%, moving from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses experienced a 9.4% increase, moving from 8,693 in 2022 to 9,513 in 2023. Consequently, the rising prevalence of sexually transmitted diseases is a key factor propelling the growth of the contraceptive device market.

What Segment Types Make Up The Contraceptive Devices Market?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Which Market Trends Are Creating New Opportunities In The Contraceptive Devices Market?

Leading companies within the contraceptive device market are developing cutting-edge products, such as contraceptive vaginal rings, to provide a convenient and low-maintenance method of birth control with just one insertion per month. A contraceptive vaginal ring functions as a flexible, hormone-emitting device inserted into the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. The EnilloRing, created by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is engineered for extended application, staying in place for three weeks, after which it is followed by a one-week ring-free interval to effectively prevent pregnancy.

Who Are The Key Players Driving Competition In The Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Read the full contraceptive devices market report here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Geographic Regions Are Influencing Demand In The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Contraceptive Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Contraceptive Devices Market At The End Of The 2026–2030 Forecast Period?

The contraceptive devices market has demonstrated robust expansion over recent years. It is projected to increase from $13.55 billion in 2025 to $14.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The market’s historical growth can be attributed to factors such as growing awareness of family planning methods, government-supported population control initiatives, an increasing occurrence of unintended pregnancies, the expansion of reproductive health services, and the rising availability of over-the-counter contraceptive products.

The contraceptive devices market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a value of $18.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This expected growth throughout the forecast period stems from factors such as a heightened focus on reproductive autonomy and women’s health, an increasing need for long-term and easily maintainable contraception, the expansion of digital health and online pharmacy platforms, the rising adoption of male contraceptive solutions, and an increase in public and NGO-led sexual health initiatives. Prominent trends for this period encompass the growing adoption of long-acting reversible contraceptives, a surge in demand for female-controlled contraceptive options, increasing acceptance of non-hormonal contraceptive devices, broadened access to contraception through online and public channels, and an intensified focus on dual protection against both pregnancy and STIs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Drivers Are Shaping The Future Growth Of The Contraceptive Devices Market?

The increasing occurrence of sexually transmitted diseases is anticipated to drive the expansion of the contraceptive device market in the foreseeable future. These infections, primarily spread via sexual contact, can impact various body parts and potentially result in diverse symptoms and health issues. The surge in sexually transmitted diseases can be attributed to heightened sexual activity, insufficient protection, inadequate sexual health education, and difficulties in accessing healthcare and testing. Contraceptive devices, particularly condoms, are crucial for combating sexually transmitted diseases as they offer a protective barrier, thereby lowering transmission risk by preventing direct contact with infected fluids and lesions. For instance, a report released in July 2024 by the UK Health Security Agency, a UK-based government body, revealed that in England, new STI diagnoses reached 401,800 in 2023, signifying a 4.7% rise from the 383,789 cases documented in 2022. Gonorrhea diagnoses specifically climbed by 7.5%, moving from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses experienced a 9.4% increase, moving from 8,693 in 2022 to 9,513 in 2023. Consequently, the rising prevalence of sexually transmitted diseases is a key factor propelling the growth of the contraceptive device market.

What Segment Types Make Up The Contraceptive Devices Market?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Which Market Trends Are Creating New Opportunities In The Contraceptive Devices Market?

Leading companies within the contraceptive device market are developing cutting-edge products, such as contraceptive vaginal rings, to provide a convenient and low-maintenance method of birth control with just one insertion per month. A contraceptive vaginal ring functions as a flexible, hormone-emitting device inserted into the vagina, which prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. The EnilloRing, created by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is engineered for extended application, staying in place for three weeks, after which it is followed by a one-week ring-free interval to effectively prevent pregnancy.

Who Are The Key Players Driving Competition In The Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Read the full contraceptive devices market report here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Geographic Regions Are Influencing Demand In The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Contraceptive Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Contraceptive Devices Market?

The contraceptive devices market has shown significant expansion in recent years. It is anticipated to increase from $13.55 billion in 2025 to $14.4 billion in 2026, registering a compound annual growth rate (CAGR) of 6.3%. The historical growth can be attributed to heightened awareness of family planning methods, government-backed population control initiatives, a rise in unintended pregnancies, the broadening of reproductive health services, and the increased availability of over-the-counter contraceptive items.

The contraceptive devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $18.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. The foreseen growth can be attributed to several factors, including an enhanced emphasis on reproductive autonomy and women’s health, a heightened need for long-term and easily manageable contraception, the expansion of digital health services and online pharmacy platforms, a rising acceptance of male contraceptive options, and an increase in sexual health programs led by public and non-governmental organizations. Key trends anticipated during this period encompass a greater uptake of long-acting reversible contraceptives, a surge in demand for female-controlled contraceptive methods, increasing approval of non-hormonal contraceptive devices, broadened availability of contraception via online and public avenues, and an intensified focus on offering dual protection against both pregnancy and STIs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Drivers Are Supporting Technological Adoption In The Contraceptive Devices Market?

The increasing incidence of sexually transmitted diseases is projected to drive the expansion of the contraceptive device market moving forward. Sexually transmitted diseases (STDs) are infections primarily transmitted via sexual contact, impacting various bodily regions and potentially resulting in a range of symptoms and health complications. The increase in sexually transmitted diseases is attributed to factors like heightened sexual activity, insufficient protection, inadequate sexual health education, and challenges concerning access to healthcare and testing. Contraceptive devices, especially condoms, are vital for sexually transmitted diseases as they establish a barrier that minimizes the transmission risk by preventing direct contact with infectious fluids and lesions. As an illustration, in July 2024, a report published by the UK Health Security Agency, a UK-based government agency, revealed 401,800 new STI diagnoses in England in 2023, indicating a 4.7% rise from the 383,789 cases recorded in 2022. Gonorrhea diagnoses saw a 7.5% increase, rising from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses climbed by 9.4%, increasing from 8,693 in 2022 to 9,513 in 2023. Therefore, the expanding prevalence of sexually transmitted diseases is fueling the growth of the contraceptive device market.

What Segment Types Are Examined In The Contraceptive Devices Market?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

What Trends Are Projected To Support The Growth Of The Contraceptive Devices Market?

Major companies in the contraceptive device market are introducing innovative products, such as contraceptive vaginal rings, to offer an accessible, low-maintenance birth control method with a monthly insertion. A contraceptive vaginal ring is a flexible, hormone-emitting device placed into the vagina that guards against pregnancy by constantly releasing hormones to impede ovulation and make cervical mucus thicker. For example, in October 2023, Xiromed LLC, a US-based pharmaceuticals firm, released the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is intended for extended use, remaining in place for three weeks. This is followed by a one-week ring-free interval to effectively prevent conception.

Who Are The Primary Competitors In The Global Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Contraceptive Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2026, By The Business Research Company

Temperature Sensor Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/temperature-sensor-global-market-report

Patient Temperature Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-temperature-monitoring-global-market-report

Patch Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/patch-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptive devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Contraceptive Devices Industry By 2029?

The size of the contraceptive devices market has demonstrated significant growth in recent years. It is projected to expand from $12.8 billion in 2024 to $13.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.9%. This historical growth can be ascribed to factors like increasing awareness regarding the importance of family planning and contraceptive methods, various government initiatives, the expanding global population, a heightened focus on women’s health and empowerment, and enhanced access to healthcare facilities.

The contraceptive devices market is projected to undergo significant expansion in the coming years. It is forecast to reach $17.25 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period is attributed to several factors including heightened awareness of sexual health and STD prevention, the economic advantages of managing family size, increasing cultural acceptance of contraceptive methods, a large segment of the young population in reproductive age, and the impact of social media in raising awareness. Prominent trends for this period include advancements in contraceptive technologies, educational efforts by NGOs and health organizations, developments in pharmaceutical formulations, the extensive availability of various contraceptive products, and investments in research and development for new birth control options.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Major Drivers Are Impacting The Contraceptive Devices Market?

The increasing incidence of sexually transmitted infections is anticipated to boost the contraceptive device market going forward. Sexually transmitted diseases (STDs) are infections primarily disseminated through sexual contact, impacting various body parts and potentially leading to a range of symptoms and health complications. The surge in sexually transmitted diseases is attributed to increased sexual activity, inadequate protection, insufficient sexual health education, and challenges in accessing healthcare and testing. Contraceptive devices, particularly condoms, are crucial for sexually transmitted diseases because they create a barrier that diminishes the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, a report from the UK Health Security Agency, a UK-based government agency, indicated that England recorded 401,800 new STI diagnoses in 2023, marking a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses of gonorrhea rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Concurrently, infectious syphilis diagnoses saw a 9.4% increase, rising from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the contraceptive device market.

Which Segment Categories Are Driving Maximum Growth In The Contraceptive Devices Market?

The contraceptive devicesmarket covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Which Long-Term Trends Will Play A Crucial Role In The Contraceptive Devices Market?

Major companies within the contraceptive device sector are developing advanced products, including contraceptive vaginal rings, to provide a convenient, minimal-maintenance birth control method requiring insertion just once a month. A contraceptive vaginal ring is a flexible, hormone-releasing device placed in the vagina that prevents conception by continuously dispensing hormones to inhibit ovulation and thicken cervical mucus. For example, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, unveiled the EnilloRing. This EnilloRing, created by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is designed for prolonged use, staying in place for three weeks, and is then followed by a one-week ring-free period to effectively prevent pregnancy.

Who Are The Dominant Players In The Contraceptive Devices Market Today?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Region Is At The Forefront Of Innovation In The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Handheld Surgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/handheld-surgical-devices-and-equipment-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Contraceptive Devices Industry By The Forecast Year 2029?

The global market for contraceptive devices has exhibited robust expansion over the past few years, projected to escalate from a valuation of $12.8 billion in 2024 to $13.55 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.9%. This upward trajectory during the historical period stems from several key factors, including heightened consciousness regarding the necessity of family planning and various birth control techniques, supportive actions from governmental bodies, a continually expanding world population, intensified emphasis on female well-being and autonomy, and enhanced accessibility to medical services.

Anticipation for the contraceptive devices sector points toward significant expansion in the near future, projecting a market valuation of $17.25 billion by 2029, fueled by a consistent compound annual growth rate of 6.2% across the projection timeframe. This upward trajectory is largely driven by heightened consciousness regarding sexual wellness and the avoidance of sexually transmitted diseases, the fiscal advantages realized through intentional family planning, heightened societal tolerance for employing birth control methods, the substantial segment of the populace within their reproductive years, and the amplifying effect of social media in disseminating relevant information. Key developments anticipated during this period encompass novelties emerging in birth control technologies, proactive educational outreach spearheaded by non-governmental organizations and medical bodies, progress in developing pharmaceutical compositions, the broad accessibility of diverse contraceptive alternatives, and elevated capital investment directed toward pioneering research for novel conception prevention techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

Which Drivers Are Supporting Growth Of The Contraceptive Devices Market?

The escalating incidence of sexually transmitted infections is anticipated to be a major catalyst for the expansion of the market for contraceptive devices in the upcoming period.These infections, transmitted predominantly via sexual encounters, can impact numerous bodily regions and result in diverse symptoms and serious health consequences.The surge in STDs is attributable to factors such as heightened levels of sexual activity, inadequate use of protective measures, insufficient education regarding sexual health, and difficulties in accessing necessary medical testing and care.Contraceptive tools, most notably condoms, are essential in mitigating the spread of STDs as they function as a physical barrier, thereby lessening the likelihood of transmission by stopping direct exposure to bodily fluids or lesions carrying the infection.To illustrate this trend, data released in July 2024 by the UK Health Security Agency, a governmental body in the United Kingdom, indicated that England registered 401,800 new STI diagnoses during 2023, representing a 4.7 percent rise compared to the 383,789 cases documented the prior year, with gonorrhea cases climbing by 7.5 percent from 79,268 in 2022 to 85,223 in 2023; additionally, diagnoses of infectious syphilis increased by 9.4 percent, growing from 8,693 in 2022 to 9,513 in 2023; Consequently, this rising rate of sexually transmitted diseases is fueling the progression of the contraceptive device market.

Which Key Segments Fueling The Contraceptive Devices Market?

The contraceptive devicesmarket covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

What Key Innovation Trends Are Fueling Advancements In The Contraceptive Devices Market?

Within the contraceptive device landscape, leading firms are focusing efforts on creating novel items like contraceptive vaginal rings, which offer users a user-friendly, infrequent maintenance approach to contraception requiring insertion only once monthly. This flexible, hormone-secreting apparatus is placed inside the vagina where it works to avert conception by steadily delivering hormones that suppress the release of eggs and increase the thickness of cervical secretions. To illustrate this progress, October 2023 saw the introduction of EnilloRing by Xiromed LLC, a pharmaceutical entity situated in the United States. This particular vaginal ring, a creation of Xiromed, incorporates both etonogestrel and ethinyl estradiol, engineered for prolonged application as it stays inserted for a duration of three weeks, succeeded by a necessary seven-day break from the device to maintain effective pregnancy prevention.

Which Leading Companies Dominate The Contraceptive Devices Market Share?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Contraceptive Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Browse Through More Reports Similar to the Global Contraceptive Devices Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Handheld Surgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/handheld-surgical-devices-and-equipment-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Contraceptive Devices Market Through 2034?

In recent times, the market size of contraceptive devices has seen substantial growth. The market is anticipated to grow from $12.8 billion in 2024, escalating to $13.55 billion in 2025 with a compound annual growth rate (CAGR) of 5.9%. The augmentation during the historic period is associated with the rising awareness regarding the significance of family planning and contraceptive procedures, initiatives taken by governments, a globally increasing population, increased attention on women’s health and empowerment, and improved accessibility to healthcare services.

The market size for contraceptive devices is projected to experience significant expansion in the coming years, reaching $17.25 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. This projected growth during the forecast period is due to several factors such as enhanced understanding of sexual health and STD prevention, the economic benefits of managing family size, the increasing cultural acceptance of contraceptives, high percentage of young people within reproductive age, and the impact of social media in raising awareness. Key trends during this time are expected to include advancements in contraceptive technologies, educational initiatives by NGOs and health organizations, breakthroughs in pharmaceutical formulations, the availability of an extensive array of contraceptive products, as well as investment towards research and development of new contraceptive methods.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

What Are the Core Market Drivers Propelling Growth in the Contraceptive Devices Industry?

The contraceptive device market stands to benefit from the rising incidence of sexually transmitted diseases (STDs). STDs are infections that spread mainly via sexual contact, affecting different parts of the body, and potentially leading to various symptoms and health issues. Factors like increased sexual activity, a lack of proper protection, inadequate sexual health knowledge, and difficulties in obtaining healthcare and testing are causing a surge in sexually transmitted diseases. Contraceptive devices and, in particular, condoms form a crucial line of defence against STDs. They offer a protective barrier that mitigates the risk of infection by avoiding direct contact with contagious fluids and sores. For example, a UK Health Security Agency report issued in July 2024 revealed that 401,800 fresh STI diagnoses were made in England in 2023, a 4.7% increase on the 383,789 reported in 2022. The number of gonorrhea cases increased by 7.5%, from 79,268 in 2022 to 85,223 in 2023, while the diagnosis of infectious syphilis saw a 9.4% rise from 8,693 cases in 2022 to 9,513 in 2023. Thus, the increasing number of sexually transmitted diseases is accelerating the escalating growth of the contraceptive device market.

How Is the Contraceptive Devices Market Segmented?

The contraceptive devicesmarket covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Which Regions Are Driving the Next Phase of the Contraceptive Devices Market Growth?

North America was the largest region in the contraceptive devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Contraceptive Devices Industry?

Leading corporations in the contraceptive device market are shifting towards the invention of unique products such as contraceptive vaginal rings. These rings offer an easy-to-use, low-maintenance birth control option with monthly placement. A contraceptive vaginal ring is a malleable device that emits hormones when inserted into the vagina, preventing conception by consistently releasing hormones that hinder ovulation and thicken the cervical mucus. For example, in October 2023, Xiromed LLC, a pharmaceutical company based in the US, launched the EnilloRing. This product, designed by Xiromed, is a contraceptive vaginal ring fusing etonogestrel and ethinyl estradiol. It is intended for extended use, staying in position for three weeks. Afterwards, there’s a week-long break without the ring to effectively ward off pregnancy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

How Is the Contraceptive Devices Market Defined and What Are Its Core Parameters?

Contraceptive devices are medical devices designed to prevent pregnancy. They come in various forms, each with different mechanisms and effectiveness. Contraceptive devices are used primarily to prevent unintended pregnancies and, in some cases, to provide protection against sexually transmitted infections (STIs).

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18320

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Contraceptive Devices Market Size Shifted, And What Is the Outlook Through 2034?

The market size for contraceptive devices has experienced considerable growth over the past few years. The industry is predicted to expand from $12.8 billion in 2024 to reach a value of $13.66 billion in 2025, signifying a compound annual growth rate (CAGR) of 6.7%. Various factors have contributed to this historic growth, including heightened awareness of family planning and contraception, government programs, a swelling global populace, an increased emphasis on women’s health and empowerment, and better access to healthcare facilities.

How Much Will the Contraceptive Devices Market Be Worth in 2029?

In the coming years, the market size for contraceptive devices is forecasted to experience significant expansion. It is anticipated to reach a valuation of $17.47 billion in 2029, with a compound annual growth rate (CAGR) of 6.4%. Factors driving this projected growth during this timeline could be heightened awareness about sexual health and prevention of STDs, economic advantages brought by family planning, growing society-wide acceptance of contraceptive usage, the high percentage of the population in their reproductive age, and the role social media plays in raising awareness. Key trends expected to impact this market during the forecast period encompass breakthroughs in contraceptive technologies, educational drives by NGOs and health bodies, advancements in medicinal formulations, the presence of a vast array of contraceptive products, and solid investments in R&D for novel contraceptive methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

Which is the Largest Company in the Contraceptive Devices Market?

Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

What Are the Main Market Drivers in the Contraceptive Devices Industry?

The escalating incidence of sexually transmitted diseases (STDs) is anticipated to fuel the expansion of the contraceptive device market. STDs are infections principally spread via sexual contact, causing various health issues and symptoms by affecting numerous body parts. The proliferation of STDs can be attributed to factors such as increased sexual activity, insufficient use of protection, a lack of adequate sexual health education, as well as difficulties in obtaining healthcare and testing. Contraceptive devices, particularly condoms, are essential in handling STDs as they present a barrier that mitigates the infection risk by averting direct contact with infected fluids and lesions. For example, as per a report published by the UK Health Security Agency, a UK government organization, in July 2024, England recorded 401,800 new STI diagnoses in 2023, indicating a 4.7% rise from the 383,789 cases reported in 2022. Gonorrhea diagnoses increased by 7.5%, surging from 79,268 in 2022 to 85,223 in 2023. Simultaneously, the diagnosis of infectious syphilis experienced a 9.4% increase, climbing from 8,693 in 2022 to 9,513 in 2023. Consequently, the escalating incidence of sexually transmitted diseases is accelerating the expansion of the contraceptive device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

How Is the Contraceptive Devices Market Segments Structured?

The contraceptive devices market covered in this report is segmented –

1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types

2) By Technology: Hormonal Contraceptives, Barrier Contraceptives

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels

Subsegments:

1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills

2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices

3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms

4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges

5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings

6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs

7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants

8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams

What Strategic Trends Are Transforming the Contraceptive Devices Market?

Preeminent organizations in the contraceptive device market are stepping towards innovation by introducing products like contraceptive vaginal rings. These devices are low-maintenance, offer convenience and only need to be inserted once a month. The vaginal ring is a flexible device that releases hormones consistently to prevent pregnancy by thickening the cervical mucus and hindering ovulation. In October 2023, Xiromed LLC, a pharmaceutical company based in the United States, initiated the launch of the EnilloRing. The EnilloRing, a byproduct of invention by Xiromed, is a contraceptive device releasing etonogestrel and ethinyl estradiol. The device is aimed for extended usage and can remain unaltered for three weeks, after which a ring-free week should be observed to ensure efficient pregnancy prevention.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Which Global Regions Offer the Highest Growth in the Contraceptive Devices Market?

North America was the largest region in the contraceptive devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18320

This Report Delivers Insight On:

1. How big is the contraceptive devices market, and how is it changing globally?

2. Who are the major companies in the contraceptive devices market, and how are they performing?

3. What are the key opportunities and risks in the contraceptive devices market right now?

4. Which products or customer segments are growing the most in the contraceptive devices market?

5. What factors are helping or slowing down the growth of the contraceptive devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model